NCT07562750

Brief Summary

"Empowered Relief" (ER) Intervention was developed by Beth Darnall, PhD at what is now the Stanford Pain Relief Innovations Lab. Our design is a randomized 3-arm study with test treatment, active control, and placebo arms. Our goals are to provide scientific evidence to demonstrate the efficacy of ER, and also provide a comparison of said efficacy against the standard of care - group pain-CBT. Treatment allocation is randomized to minimize confounder effects. Statisticians performing analyses will be blinded. The primary objective of this study is to evaluate the efficacy of Empowered Relief (a novel, single-session (2-hour), evidence-based online pain management class) on reducing pain burden and improving quality of life in patients with advanced osteoarthritis. Empowered Relief is designed to compress key cognitive behavioral therapy (CBT) skills, mindfulness principles, and pain neuroscience education into a brief, scalable format. Specifically, the study aims to: Evaluate Clinical Outcomes: Determine whether the intervention reduces pain burden and enhances mobility. Assess Psychological \& Behavioral Impact: Examine whether the intervention improves patient-reported understanding of pain, fosters self-efficacy, and increases perceived control, thereby promoting active engagement in their own pain management. Subject Population: The subject population consists of adult patients diagnosed with advanced osteoarthritis (KL Grade 3-4) who have been deferred from total hip or total knee arthroplasty (THA/TKA). Deferment criteria for this population include existing medical, surgical, behavioral, or personal barriers that currently preclude them from undergoing joint replacement surgery. This population is particularly vulnerable to prolonged suffering, decreased mobility, and compounding psychosocial distress while managing severe somatic pain without immediate surgical options. Main Research Procedures: The study will utilize a prospective, longitudinal design to measure the impact of the Empowered Relief intervention on the target population. The main procedures include: Intervention Delivery: Eligible participants will complete the live Empowered Relief online class (via Zoom) with a certified instructor (Dr. Caryn Lindsey), a 2-hour intervention equipping them with accessible, evidence-based behavioral pain management skills. Data Collection Schedule: Participants will be assessed at three distinct time points: Baseline (pre-intervention), 4-weeks post-treatment, and 8-weeks post-treatment.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
23mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Apr 2026Apr 2028

Study Start

First participant enrolled

April 14, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 15, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2028

Expected
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2028

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

April 15, 2026

Last Update Submit

April 28, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain Catastrophizing Scale (PCS)

    Once at baseline, then at weeks 2, 4, 8, and 12.

  • NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Measures

    Questions related to pain, physical function, and depression.

    Once at baseline, then at weeks 2, 4, 8, and 12

  • Pain Self-Efficacy Questionnaire

    Once at baseline, then at weeks 2, 4, 8, and 12

Study Arms (2)

Test Treatment

EXPERIMENTAL
Behavioral: Empowered Relief

Educational Materials

ACTIVE COMPARATOR

Patients will be provided with a handout from the U.S. Pain Foundation titled "Self Management Strategies"

Behavioral: "Self Management Strategies" handout

Interventions

2-hour pain management course

Test Treatment

"Self Management Strategies" is an educational handout from the US Pain Foundation

Educational Materials

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults age 18 or older who are eligible and interested in enrolling

You may not qualify if:

  • Any records flagged "break the glass" or "research opt out"

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cedars Sinai

Los Angeles, California, 90048, United States

Location

Related Publications (3)

  • 3. Wertli, M.M., et al., The Influence of Catastrophizing on Treatment Outcome in Patients With Non-Specific Low Back Pain: A Systematic Review. Spine (Phila Pa 1976), 2013.

    BACKGROUND
  • 2. CDC, Prevalence and Most Common Causes of Disability Among Adults --- United States, 2005. MMWR, 2009. 58(16): p. 421-416.

    BACKGROUND
  • 1. Freburger, J.K., et al., The rising prevalence of chronic low back pain. Arch Intern Med, 2009. 169(3): p. 251-8.

    BACKGROUND

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 15, 2026

First Posted

May 1, 2026

Study Start

April 14, 2026

Primary Completion (Estimated)

April 14, 2028

Study Completion (Estimated)

April 16, 2028

Last Updated

May 1, 2026

Record last verified: 2026-04

Locations